Search details
1.
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.
Lancet
; 403(10437): 1649-1659, 2024 Apr 27.
Article
in English
| MEDLINE | ID: mdl-38582092
2.
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
N Engl J Med
; 382(7): 597-609, 2020 02 13.
Article
in English
| MEDLINE | ID: mdl-31825569
3.
Adipocyte Microenvironment in Ovarian Cancer: A Critical Contributor?
Int J Mol Sci
; 24(23)2023 Nov 22.
Article
in English
| MEDLINE | ID: mdl-38068912
4.
Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study.
Future Oncol
; 18(33): 3677-3688, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-36300423
5.
Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue.
BMC Cancer
; 18(1): 495, 2018 05 02.
Article
in English
| MEDLINE | ID: mdl-29716546
6.
Beta-Adrenergic Blockade in Advanced Non-Small Cell Lung Cancer Patients Receiving Immunotherapy: A Multicentric Study.
Cureus
; 16(1): e52194, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38348009
7.
Optimal [18F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial.
J Nucl Med
; 65(5): 708-713, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38575192
8.
Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer.
Cancers (Basel)
; 15(3)2023 Jan 25.
Article
in English
| MEDLINE | ID: mdl-36765690
9.
Correction: Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer.
Cureus
; 15(1): c91, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36636523
10.
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial.
Neuro Oncol
; 25(1): 157-166, 2023 01 05.
Article
in English
| MEDLINE | ID: mdl-35639825
11.
Non-endometrioid endometrial cancer: Analysis of different adjuvant treatment modalities.
Cancer Treat Res Commun
; 32: 100581, 2022.
Article
in English
| MEDLINE | ID: mdl-35675758
12.
Refining Therapy in Patients with HER2-Positive Breast Cancer with Central Nervous System Metastasis.
Breast Care (Basel)
; 17(6): 524-532, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36590149
13.
Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer.
Cureus
; 14(11): e31144, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36505147
14.
Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab.
Breast Cancer Res Treat
; 127(3): 841-4, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21369716
15.
Uterine Sarcomas: A Retrospective Analysis of a Cohort of 62 Patients.
Cureus
; 13(2): e13349, 2021 Feb 15.
Article
in English
| MEDLINE | ID: mdl-33747651
16.
Next-Generation Sequencing in Breast Cancer Management: A Case Report of Genomic Tumour Evolution over Time.
Case Rep Oncol
; 14(2): 1212-1219, 2021.
Article
in English
| MEDLINE | ID: mdl-34703438
17.
Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments.
Front Oncol
; 11: 815772, 2021.
Article
in English
| MEDLINE | ID: mdl-35155205
18.
Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses.
Oncotarget
; 12(24): 2388-2403, 2021 Nov 23.
Article
in English
| MEDLINE | ID: mdl-34853660
19.
Human Microbiota and Breast Cancer-Is There Any Relevant Link?-A Literature Review and New Horizons Toward Personalised Medicine.
Front Microbiol
; 12: 584332, 2021.
Article
in English
| MEDLINE | ID: mdl-33716996
20.
Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer.
Cancers (Basel)
; 13(15)2021 Jul 30.
Article
in English
| MEDLINE | ID: mdl-34359741